With support from EDB and A*Star, Japanese biopharma leader Chugai is using its research base in Singapore to create new ...

Vyvgart and robust R&D, balanced by risks and diversification potential. Read here for more analysis of ARGX stock.

Researchers found that zeaxanthin, long associated with eye health, may also boost the body’s immune response against cancer. In a recent study, scientists at the University of Chicago found that ...

Systemic lupus erythematosus is a clinically and immunologically heterogenous, systemic autoimmune disease characterized by ...

Natural antihistamines such as black pepper extract, vitamin C, butterbur, and quercetin may help provide relief for ...

Discover Alector's latest breakthroughs in neurodegenerative disease therapies, including updates on Alzheimer's and Parkinson's programs.

Peptides called alpha-defensins shape which gut bacteria thrive and which are weeded out, revealing that our bodies aren't ...

Accomplished biopharma executive and entrepreneur brings a 25-year track record of upscaling valuable companies and realizing the potential of ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

Some infants fed blueberry powder every day from age 5 months to 12 months had resolved respiratory symptoms, whereas this ...

After decades without much movement, a handful of new treatments for this rare autoimmune disease are now approved, and ...

Aptamer Group plc (AIM: APTA), the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that it has signed a new therapeutic development agreement with ...